Oxtellar Xr Tablet
Product Images NDC 17772-121

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxtellar Xr (NDC 17772-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Supernus Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxtellar Xr 01)

Chemical structure of oxcarbazepine, the active ingredient in OXTELLAR XR tablets. The diagram shows the molecular framework including rings and functional groups characteristic of oxcarbazepine.*

FDA Label Image

Package Label (Principal Display Panel)

Oxtellar XR 150 mg extended-release tablets packaging label showing 100 tablets. The label includes the drug's generic name oxcarbazepine, prescribing instructions to swallow whole once daily, and a warning for pharmacists to dispense the medication guide. Manufactured for Supernus Pharmaceuticals, Inc., with storage instructions and a barcode present.*

FDA Label Image

Package Label (Principal Display Panel)

Packaging label for Oxtellar XR 300 mg tablets (oxcarbazepine) extended-release, oral dosage form. The label states 'Once daily' with instructions to swallow whole without cutting, crushing, or chewing. It lists the manufacturer as Patheon Inc., Whitby, Ontario, Canada, and the labeler as Supernus Pharmaceuticals, Inc., Rockville, MD. The package contains 100 tablets and includes storage instructions to protect from light and moisture and maintain controlled room temperature.*

FDA Label Image

Package Label (Principal Display Panel)

Label for Oxtellar XR 600 mg extended-release tablets (oxcarbazepine) by Supernus Pharmaceuticals, Inc. The label indicates oral tablets, 100 count, with instructions to swallow whole once daily. It includes storage instructions and manufacturer details for Patheon Inc. in Canada and Supernus Pharmaceuticals in the USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.